| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer
|
Kwong, Ava
|
|
2009
|
117 |
3 |
p. 683-686
|
artikel
|
| 2 |
Absence of the BRCA1 del (exons 9–12) mutation in breast/ovarian cancer families outside of Mexican Hispanics
|
Torres, Diana
|
|
2009
|
117 |
3 |
p. 679-681
|
artikel
|
| 3 |
A comprehensive evaluation of outcomes for inflammatory breast cancer
|
Yang, Relin
|
|
2009
|
117 |
3 |
p. 631-641
|
artikel
|
| 4 |
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
|
Sverrisdottir, A.
|
|
2009
|
117 |
3 |
p. 561-567
|
artikel
|
| 5 |
Alcohol intake over the life course and mammographic density
|
Flom, Julie D.
|
|
2009
|
117 |
3 |
p. 643-651
|
artikel
|
| 6 |
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort
|
Lynn Henry, N.
|
|
2009
|
117 |
3 |
p. 571-575
|
artikel
|
| 7 |
Axillary web syndrome after axillary dissection in breast cancer: a prospective study
|
Torres Lacomba, María
|
|
2009
|
117 |
3 |
p. 625-630
|
artikel
|
| 8 |
Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study
|
Greenlee, Heather
|
|
2009
|
117 |
3 |
p. 653-665
|
artikel
|
| 9 |
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance
|
Apostolaki, Stella
|
|
2009
|
117 |
3 |
p. 539
|
artikel
|
| 10 |
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance
|
Apostolaki, Stella
|
|
2008
|
117 |
3 |
p. 525-534
|
artikel
|
| 11 |
Do GnRH analogs protect against ovarian toxicity of chemotherapy?
|
Moore, Halle C. F.
|
|
2009
|
117 |
3 |
p. 569-570
|
artikel
|
| 12 |
Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy
|
Papi, Laura
|
|
2008
|
117 |
3 |
p. 497-504
|
artikel
|
| 13 |
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation
|
Leong, Hoyee
|
|
2008
|
117 |
3 |
p. 505-515
|
artikel
|
| 14 |
Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer
|
Bewick, Mary A.
|
|
2009
|
117 |
3 |
p. 667-669
|
artikel
|
| 15 |
HER2 as marker for the detection of circulating tumor cells
|
Müller, Volkmar
|
|
2009
|
117 |
3 |
p. 535-537
|
artikel
|
| 16 |
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
|
Hines, Stephanie L.
|
|
2009
|
117 |
3 |
p. 603-609
|
artikel
|
| 17 |
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment
|
Zhou, Xiaolei
|
|
2009
|
117 |
3 |
p. 577-589
|
artikel
|
| 18 |
Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment
|
Stanton, Anthony W. B.
|
|
2008
|
117 |
3 |
p. 549-557
|
artikel
|
| 19 |
Lysis of cancer cells by autologous T cells in breast cancer pleural effusates treated with anti-EpCAM BiTE antibody MT110
|
Witthauer, Juliane
|
|
2008
|
117 |
3 |
p. 471-481
|
artikel
|
| 20 |
Measuring lymphedema in patients with breast cancer: go with the flow?
|
Hunt, Kelly K.
|
|
2009
|
117 |
3 |
p. 559-560
|
artikel
|
| 21 |
Never use anthracyclines with trastuzumab: it is time to reconsider the taboo
|
Gianni, Luca
|
|
2009
|
117 |
3 |
p. 599-601
|
artikel
|
| 22 |
Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial
|
Stickeler, Elmar
|
|
2009
|
117 |
3 |
p. 591-598
|
artikel
|
| 23 |
Quantitative bioimpedance spectroscopy for the assessment of lymphoedema
|
Ward, L. C.
|
|
2008
|
117 |
3 |
p. 541-547
|
artikel
|
| 24 |
Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003
|
Canfell, Karen
|
|
2009
|
117 |
3 |
p. 671-673
|
artikel
|
| 25 |
Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model
|
Ruhlen, Rachel L.
|
|
2008
|
117 |
3 |
p. 517-524
|
artikel
|
| 26 |
Test of Hardy–Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions
|
Yu, Ke-Da
|
|
2009
|
117 |
3 |
p. 675-677
|
artikel
|
| 27 |
The effect of transcutaneous electrical nerve stimulation on postmastectomy skin flap necrosis
|
Atalay, Can
|
|
2009
|
117 |
3 |
p. 611-614
|
artikel
|
| 28 |
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer
|
Mayer, E. L.
|
|
2009
|
117 |
3 |
p. 615-623
|
artikel
|
| 29 |
Validation of 70-gene prognosis signature in node-negative breast cancer
|
Bueno-de-Mesquita, J. M.
|
|
2008
|
117 |
3 |
p. 483-495
|
artikel
|
Tijdschrift beschrijving